Skip to main content

Advertisement

SpringerLink
Log in

Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Peripheral blood lymphocytes (PBL) and tumor-infiltrating lymphocytes (TIL) were isolated from six cancer patients and cultured in the presence of 100 units/ml of recombinant interleukin 2 (IL2). Both IL2-stimulated PBL (IL2-PBL) and IL2-stimulated TIL (IL2-TIL) lysed fresh and short-term cultured autologous tumor cells in four and six cases, respectively. In four out of six patients IL2-TIL showed a slightly higher tumor cytotoxicity than IL2-PBL without lysing autologous normal PBL or TIL. Like IL2-PBL, IL2-TIL also killed allogeneic fresh and cultured targets of different histotypes, suggesting a lack of autologous tumor cytotoxic specificity. TIL cultured for 3 weeks in IL2 maintained their killing activity against autologous and allogeneic tumor targets. Phenotypic analysis of uncultured TIL showed a predominance of CD3+ T cells (∼70%) with CD4+ (∼60%) and CD8+ (20%) lymphocyte subsets, whereas ≤3% of CD16+ natural killer cells were present. TIL but not PBL contained 12%–19% of lymphocytes which expressed activation markers such as DR and TAC. The culture of both TIL and PBL in IL2 for 2–3 weeks induced an increase in the percentage of CD8+ and a decrease in CD4+ and augmentation of Leu 19+, DR+, and TAC+ cells. These results indicate that IL2-TIL can lyse autologous tumor cells slightly better than IL2-PBL, although such an effect was also evident against allogeneic neoplastic targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allavena P, Zanaboni F, Rossini S, Merendino A, Bonazzi C, Vassena L, Mangioni C, Mantovani A (1986) Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors. J Natl Cancer Inst 77:863

    Google Scholar 

  2. Anichini A, Fossati G, Parmiani G (1987) Clonal analysis of cytolytic T cell response to human tumors. Immunol Today 8:385

    Google Scholar 

  3. Burns GF, Good MF, Riglar C, Bartlett PF, Crapper RM, Mackay IR (1984) Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood. Clin Exp Immunol 57:487

    Google Scholar 

  4. Fossati G, Taramelli D, Balsari A, Bogdanovich G, Andreola S, Parmiani G (1984) Primary but not metastatic melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer 33:591

    Google Scholar 

  5. Hayry P, Totterman TH (1978) Cytological and functional analysis of inflammatory infiltrates in human malignant tumours. 1. Composition of inflammatory infiltrates. Eur J Immunol 8:866

    Google Scholar 

  6. Heo DS, Whiteside TL, Johnson JT, Chen K, Barnes EL, Herberman RB (1987) Long-term interleukin 2 growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Cancer Res 47:6353

    Google Scholar 

  7. Herberman RB, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R, Golub S, Lanier LL, Phillips JH, Riccardi C, Ritz J, Santoni A, Schmidt RE, Uchida A (1987) Lymphokine-activated killer cell activity. Immunol Today 8:178

    Article  Google Scholar 

  8. Hersey P, Bindon C, Edwards A, Murray E, Phillips G, McCarthy WH (1981) Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2. Int J Cancer 28:695

    Google Scholar 

  9. Ioachim HL (1976) The stroma reaction of tumours: an expression of immune surveillance. J Natl Cancer Inst 57:465

    Google Scholar 

  10. Itoh K, Tilden AB, Balch CM (1986) Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res 46:3011

    Google Scholar 

  11. Kradin RL, Boyle LA, Preffer FI, Callahan RJ, Barlai-Kovach M, Strauss HW, Dubinett S, Kurnick JT (1987) Tumorderived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother 24:76

    Google Scholar 

  12. Mantovani A, Allavena P, Sessa C, Bolis G, Mangioni C (1980) Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors. Int J Cancer 25:573

    Google Scholar 

  13. McGovern FJ, Shaw HM, Milton CW, Farago GA (1979) Prognostic significance of the histological features of malignant melanoma. Histopathology 3:385

    Google Scholar 

  14. Miescher S, Whiteside TL, Carrel S, Van Fliedner V (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899

    Google Scholar 

  15. Miescher S, Whiteside TL, Moretta L, Von Fliedner V (1987) Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. J Immunol 138:4004

    Google Scholar 

  16. Moy PM, Holmes EC, Golub SH (1985) Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res 45:57

    Google Scholar 

  17. Mukherji B, Wilhelm SA, Guha A, Ergin MT (1986) Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response. J Immunol 136:1888

    Google Scholar 

  18. Muul LM, Spiess PJ, Director EP, Rosenberg SA (1987) Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 138:989

    Google Scholar 

  19. Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A (1987) Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 47:173

    Google Scholar 

  20. Rosenberg SA (1985) Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. J Natl Cancer Inst 75:595

    Google Scholar 

  21. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318

    Google Scholar 

  22. Santoli D, Tweardy DJ, Ferrero D, Kreider BL, Rovera G (1986) A suppressor lymphokine produced by human T leukemia cell lines. J Exp Med 163:18

    Google Scholar 

  23. Sondel PM, Hank JA, Kohler PC, Chen BP, Minkoff DZ, Molenda JA (1986) Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells. J Immunol 137:502

    Google Scholar 

  24. Spiess PJ, Yang JC, Rosenberg SA (1987) In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin 2. J Natl Cancer Inst 79:1067

    Google Scholar 

  25. Taramelli D, Fossati G, Balsari A, Marolda R, Parmiani G (1984) The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells. Int J Cancer 34:797

    Google Scholar 

  26. Totterman TH, Hayry P, Saksela E, Timonen T, Eklund B (1978) Cytological and functional analysis of inflammatory infiltrates in human malignant tumours. II. Functional investigations of the infiltrating cells. Eur J Immunol 8:872

    Google Scholar 

  27. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B (1984) Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160:1147

    Google Scholar 

  28. Underwood JCE (1974) Lymphoreticular infiltration in human tumours: prognostic and biological implication: a review. Br J Cancer 30:538

    Google Scholar 

  29. Vose BM (1982) Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site. Int J Cancer 30:135

    Google Scholar 

  30. Vose BM (1987) Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators. Cancer Metastasis Rev 5:299

    Google Scholar 

  31. Vose BM, Moore M (1979) Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer 24:579

    Google Scholar 

  32. Vose BM, Vanky F, Klein E (1977) Human tumour-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph node lymphocytes with autologous tumour cells. Int J Cancer 20:895

    Google Scholar 

  33. Vose BM, Vanky F, Argov S, Klein E (1977) Natural cytotoxicity in man: activity of lymph node and tumour-infiltrating lymphocytes. Eur J Immunol 7:753

    Google Scholar 

  34. Whiteside TL, Miescher S, Hurlimann J, Moretta L, Von Fliedner V (1986) Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. Int J Cancer 37:803

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I-20133, Milan, Italy

    Marina Radrizzani, Carlo Gambacorti-Passerini, Giorgio Parmiani & Giuseppe Fossati

Authors
  1. Marina Radrizzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Gambacorti-Passerini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgio Parmiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Fossati
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was in part supported by grant N. 86.00663.44 of the Finalized Project Oncology of CNR (Rome, Italy) and by Italian Association for Cancer Research (Milan, Italy)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radrizzani, M., Gambacorti-Passerini, C., Parmiani, G. et al. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells. Cancer Immunol Immunother 28, 67–73 (1989). https://doi.org/10.1007/BF00205803

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205803

Keywords

Search

Navigation